一种新的治疗方法将治愈耐多药结核病的时间缩短了一半,并且拥有更小的副作用。这些表现出良好前景的结果来自在非洲和乌兹别克斯坦开展的两项临床试验。研究表明,同治疗该疾病的现有疗法相比,最新疗法还拥有更高的成功率,并且费用更 A new treatment will cut the time to MDR-TB treatment in half and will have even fewer side effects. These results, which show good prospects, come from two clinical trials in Africa and Uzbekistan. Research shows that newer therapies also have a higher success rate and cost more when compared to current treatments for the disease